- Home
- CHW vs CYRX Comparison
CHW vs CYRX Comparison
Compare CHW & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHW
- CYRX
- Stock Information
- Founded
- CHW 2007
- CYRX 1999
- Country
- CHW United States
- CYRX United States
- Employees
- CHW N/A
- CYRX N/A
- Industry
- CHW Investment Managers
- CYRX Biotechnology: Pharmaceutical Preparations
- Sector
- CHW Finance
- CYRX Health Care
- Exchange
- CHW Nasdaq
- CYRX Nasdaq
- Market Cap
- CHW 431.1M
- CYRX 422.6M
- IPO Year
- CHW N/A
- CYRX N/A
- Fundamental
- Price
- CHW $6.83
- CYRX $7.50
- Analyst Decision
- CHW
- CYRX Buy
- Analyst Count
- CHW 0
- CYRX 7
- Target Price
- CHW N/A
- CYRX $13.14
- AVG Volume (30 Days)
- CHW 195.2K
- CYRX 275.6K
- Earning Date
- CHW 01-01-0001
- CYRX 03-11-2025
- Dividend Yield
- CHW 9.27%
- CYRX N/A
- EPS Growth
- CHW N/A
- CYRX N/A
- EPS
- CHW N/A
- CYRX N/A
- Revenue
- CHW N/A
- CYRX $226,113,000.00
- Revenue This Year
- CHW N/A
- CYRX N/A
- Revenue Next Year
- CHW N/A
- CYRX $7.70
- P/E Ratio
- CHW N/A
- CYRX N/A
- Revenue Growth
- CHW N/A
- CYRX N/A
- 52 Week Low
- CHW $5.07
- CYRX $5.32
- 52 Week High
- CHW $6.54
- CYRX $20.11
- Technical
- Relative Strength Index (RSI)
- CHW 48.22
- CYRX 43.82
- Support Level
- CHW $6.64
- CYRX $6.97
- Resistance Level
- CHW $6.81
- CYRX $8.97
- Average True Range (ATR)
- CHW 0.10
- CYRX 0.55
- MACD
- CHW 0.01
- CYRX -0.12
- Stochastic Oscillator
- CHW 46.34
- CYRX 26.50
About CHW Calamos Global Dynamic Income Fund
Calamos Global Dynamic Income Fund operates as a closed-end management investment company. The company's investment strategy is to generate a high level of current income with the objective of capital appreciation. It dynamically allocates its investment among equities, convertible bonds, fixed-income securities and alternative investments.
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.